Evaxion Biotech AS (EVAX)
3.91
-0.26
(-6.24%)
USD |
NASDAQ |
May 01, 16:00
4.05
+0.14
(+3.58%)
After-Hours: 20:00
Evaxion Biotech Shares Outstanding: 5.215M for March 15, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 15, 2024 | 5.215M |
February 05, 2024 | 4.812M |
January 29, 2024 | 4.054M |
January 26, 2024 | 4.054M |
January 11, 2024 | 3.791M |
January 04, 2024 | 3.790M |
December 31, 2023 | 3.790M |
December 21, 2023 | 3.790M |
November 01, 2023 | 2.792M |
October 13, 2023 | 2.787M |
September 30, 2023 | 2.781M |
September 25, 2023 | 2.766M |
September 13, 2023 | 2.765M |
August 11, 2023 | 2.765M |
July 11, 2023 | 2.764M |
June 30, 2023 | 2.764M |
June 09, 2023 | 2.687M |
March 31, 2023 | 2.644M |
March 22, 2023 | 2.642M |
February 24, 2023 | 2.642M |
Date | Value |
---|---|
February 02, 2023 | 2.528M |
December 31, 2022 | 2.414M |
December 27, 2022 | 2.414M |
September 23, 2022 | 2.398M |
June 30, 2022 | 2.383M |
June 07, 2022 | 2.326M |
May 19, 2022 | 2.326M |
May 15, 2022 | 2.326M |
April 12, 2022 | 2.320M |
March 31, 2022 | 2.320M |
December 31, 2021 | 2.320M |
November 09, 2021 | 2.314M |
September 30, 2021 | 1.920M |
June 30, 2021 | 1.920M |
June 23, 2021 | 1.920M |
May 26, 2021 | 1.920M |
March 31, 2021 | 1.920M |
February 05, 2021 | 1.920M |
January 25, 2021 | 1.895M |
December 31, 2020 | 1.620M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.620M
Minimum
Dec 31 2020
5.215M
Maximum
Mar 15 2024
2.738M
Average
2.585M
Median
Shares Outstanding Benchmarks
Ascendis Pharma A/S | 56.61M |
DBV Technologies SA | 192.34M |
Cellectis SA | 71.95M |
Adaptimmune Therapeutics PLC | 246.83M |
Akari Therapeutics PLC | 7.924M |